Back to Results

The Joint Corp (JYNT)

The Joint Corp. is a healthcare company that operates and franchises chiropractic clinics across the United States. Through its franchise model, the company supports clinic development and day-to-day operations by providing franchisees and staff with training, site selection assistance, construction and vendor coordination, and ongoing operational support. Its clinics focus on routine chiropractic adjustments delivered through a private-pay, non-insurance cash model. Founded in 2010 and based in Scottsdale, Arizona, The Joint Corp. is listed on the NASDAQ under the ticker JYNT as common stock.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-JYNT
$9.66
15.2% Upside
Fair
$10
19.3% Upside
Undervalued
Good
0.0%
November 5, 2026
55.6x
7.3x
2.0x
114 M
95.413 M
1.7%
48.0%
3.1
203.4%
Valuation • Fair Value

The Joint Corp (NASDAQ-JYNT) Fair Value by Valuation Model

Review the available estimates for The Joint Corp (NASDAQ-JYNT), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$9.66

Estimated upside of 15.2% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$11.27

Discounted cash flow valuation reference.

Ben Graham Formula Value

$1.70

Classic Ben Graham valuation formula reference.

EPV Fair Value

$8.18

Earnings power value estimate.

Comps Fair Value

$8.29

Comparable-company valuation reference.

Analyst Price Target

$10

Analysts imply upside of 19.3%.

How to read these valuation models

Use the 7 available valuation references for The Joint Corp (NASDAQ-JYNT) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for The Joint Corp (NASDAQ-JYNT)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

58.55 M

Current operating scale indicator.

Revenue Forecast

60.609 M

Forward revenue estimate.

EBITDA

4.021 M

Current operating profitability reference.

EBITDA Forecast

12.413 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review The Joint Corp (NASDAQ-JYNT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for The Joint Corp (NASDAQ-JYNT)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

-3.05

No elevated caution signal from this screen.

Altman Z-Score

3.1

Relatively strong balance-sheet zone.

FCF / Net Income

203.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for The Joint Corp (NASDAQ-JYNT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for The Joint Corp (NASDAQ-JYNT)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 5, 2026

Days to Earnings

44

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for The Joint Corp (NASDAQ-JYNT), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

The Joint Corp (NASDAQ-JYNT) Stock Forecast & Technical Outlook

Review The Joint Corp (NASDAQ-JYNT) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for The Joint Corp (NASDAQ-JYNT) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for The Joint Corp (NASDAQ-JYNT) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for The Joint Corp (NASDAQ-JYNT) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for The Joint Corp (NASDAQ-JYNT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for The Joint Corp (NASDAQ-JYNT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for The Joint Corp (NASDAQ-JYNT)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, The Joint Corp (NASDAQ-JYNT) has a Hold consensus, with 1 buy, 3 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 3
Sell 0
FAQ • Fast Investor Answers

The Joint Corp (NASDAQ-JYNT) Stock FAQ

Data-supported answers about The Joint Corp (NASDAQ-JYNT), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$9.66
Estimated upside 15.2%
Valuation Rating
Undervalued
Estimated upside of 15.2%
Analyst Target
$10
Implied upside 19.3%
Financial Health
Good
Current financial-health read

The current fair value estimate for The Joint Corp (NASDAQ-JYNT) is $9.66. This implies an estimated upside of 15.2% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 15.2% versus the current market price.

The available analyst price target for The Joint Corp (NASDAQ-JYNT) is $10. The analyst target implies estimated upside of 19.3%.

The current financial health read for The Joint Corp (NASDAQ-JYNT) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for The Joint Corp (NASDAQ-JYNT) is November 5, 2026.

The latest available data indicates no current dividend yield for The Joint Corp (NASDAQ-JYNT).

The current P/E ratio listed for The Joint Corp (NASDAQ-JYNT) is 55.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for The Joint Corp is 114 M.

The current enterprise value listed for The Joint Corp is 95.413 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for The Joint Corp is NASDAQ-JYNT, and the stock is listed on NASDAQ.

The Joint Corp (NASDAQ-JYNT) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for The Joint Corp is 1.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for The Joint Corp is 48.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Undervalued Market Cap 334.8 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 111.4 B
MCK NYSE McKesson Corporation Fair Value Undervalued Market Cap 103.9 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 94.854 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 87.275 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 72.333 B
COR NYSE Cencora Inc Fair Value Fair Market Cap 60.002 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 51.415 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 44.67 B
CNC NYSE Centene Corp Fair Value Undervalued Market Cap 31.27 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 25.911 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 25.266 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 23.774 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.101 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.111 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 11.925 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 11.79 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.716 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 10.567 B
ENSG NASDAQ The Ensign Group Inc Fair Value Fair Market Cap 10.19 B